The particle in question, known as a sterile neutrino, was supposed to only interact with gravity and have zero interactions ...
Spencer Axani, assistant professor in the Department of Physics and Astronomy, is the inventor of CosmicWatch, a portable, low-cost particle detector that tracks muons, invisible particles that ...
A team of quantum physicists has taken a concept that once lived purely in equations and turned it into hardware reality, ...
China’s decision to halt work on what was meant to be the world’s largest particle accelerator marked a sharp turn in the ...
In a short talk at Caltech, physicist Richard Feynman laid out a vision of manipulating and controlling atoms at the tiniest ...
Picture a particle physicist. What do they look like as they do their research? There's a certain popular image of what a scientist looks like while they make their discoveries, according to Dr.
Jackson Ryan was CNET's science editor, and a multiple award-winning one at that. Earlier, he'd been a scientist, but he realized he wasn't very happy sitting at a lab bench all day. Science writing, ...
Physicists at the world's largest atom smasher have detected a mysterious, primordial particle from the dawn of time. About 100 of the short-lived "X" particles — so named because of their unknown ...
BETHLEHEM, Pa., June 22, 2011 /PRNewswire/ -- In a recent announcement by Neurelis, a proprietary intranasal formulation of diazepam (NRL-1) achieved positive clinical results in a Phase I ...
CLEVELAND, January 9, 2019 - The Lubrizol Corporation announces its contract development and manufacturing organization (CDMO), Particle Sciences, a Lubrizol LifeSciences company, has strengthened its ...
BETHLEHEM, Pa., April 28 /PRNewswire/ -- Particle Sciences, Inc. today announced the appointment of Robert W. Lee, Ph.D. to the position of Vice President, Pharmaceutical Development. Dr. Lee joins ...
BETHLEHEM, Pa., June 22, 2011 /PRNewswire/ -- In a recent announcement by Neurelis, a proprietary intranasal formulation of diazepam (NRL-1) achieved positive clinical results in a Phase I ...